Cargando…
The role transition of radiotherapy for the treatment of liver cancer in the COVID-19 era
The uncontrollable COVID-19 crises in the SARS-CoV-2 high-prevalence areas have greatly disrupted the routine treatment of liver cancer and triggered a role transformation of radiotherapy for liver cancer. The weight of radiotherapy in the treatment algorithm for liver cancer has been enlarged by th...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9516283/ https://www.ncbi.nlm.nih.gov/pubmed/36185295 http://dx.doi.org/10.3389/fonc.2022.976143 |
_version_ | 1784798674117722112 |
---|---|
author | Li, Zheng Hu, Yue Zeng, Ming Hu, Qinyong Ye, Fei Liu, Ruifeng Cai, Hongyi Li, Qiang Wang, Xiaohu |
author_facet | Li, Zheng Hu, Yue Zeng, Ming Hu, Qinyong Ye, Fei Liu, Ruifeng Cai, Hongyi Li, Qiang Wang, Xiaohu |
author_sort | Li, Zheng |
collection | PubMed |
description | The uncontrollable COVID-19 crises in the SARS-CoV-2 high-prevalence areas have greatly disrupted the routine treatment of liver cancer and triggered a role transformation of radiotherapy for liver cancer. The weight of radiotherapy in the treatment algorithm for liver cancer has been enlarged by the COVID-19 pandemic, which is helpful for the optimal risk-benefit profile. |
format | Online Article Text |
id | pubmed-9516283 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-95162832022-09-29 The role transition of radiotherapy for the treatment of liver cancer in the COVID-19 era Li, Zheng Hu, Yue Zeng, Ming Hu, Qinyong Ye, Fei Liu, Ruifeng Cai, Hongyi Li, Qiang Wang, Xiaohu Front Oncol Oncology The uncontrollable COVID-19 crises in the SARS-CoV-2 high-prevalence areas have greatly disrupted the routine treatment of liver cancer and triggered a role transformation of radiotherapy for liver cancer. The weight of radiotherapy in the treatment algorithm for liver cancer has been enlarged by the COVID-19 pandemic, which is helpful for the optimal risk-benefit profile. Frontiers Media S.A. 2022-09-14 /pmc/articles/PMC9516283/ /pubmed/36185295 http://dx.doi.org/10.3389/fonc.2022.976143 Text en Copyright © 2022 Li, Hu, Zeng, Hu, Ye, Liu, Cai, Li and Wang https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Oncology Li, Zheng Hu, Yue Zeng, Ming Hu, Qinyong Ye, Fei Liu, Ruifeng Cai, Hongyi Li, Qiang Wang, Xiaohu The role transition of radiotherapy for the treatment of liver cancer in the COVID-19 era |
title | The role transition of radiotherapy for the treatment of liver cancer in the COVID-19 era |
title_full | The role transition of radiotherapy for the treatment of liver cancer in the COVID-19 era |
title_fullStr | The role transition of radiotherapy for the treatment of liver cancer in the COVID-19 era |
title_full_unstemmed | The role transition of radiotherapy for the treatment of liver cancer in the COVID-19 era |
title_short | The role transition of radiotherapy for the treatment of liver cancer in the COVID-19 era |
title_sort | role transition of radiotherapy for the treatment of liver cancer in the covid-19 era |
topic | Oncology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9516283/ https://www.ncbi.nlm.nih.gov/pubmed/36185295 http://dx.doi.org/10.3389/fonc.2022.976143 |
work_keys_str_mv | AT lizheng theroletransitionofradiotherapyforthetreatmentoflivercancerinthecovid19era AT huyue theroletransitionofradiotherapyforthetreatmentoflivercancerinthecovid19era AT zengming theroletransitionofradiotherapyforthetreatmentoflivercancerinthecovid19era AT huqinyong theroletransitionofradiotherapyforthetreatmentoflivercancerinthecovid19era AT yefei theroletransitionofradiotherapyforthetreatmentoflivercancerinthecovid19era AT liuruifeng theroletransitionofradiotherapyforthetreatmentoflivercancerinthecovid19era AT caihongyi theroletransitionofradiotherapyforthetreatmentoflivercancerinthecovid19era AT liqiang theroletransitionofradiotherapyforthetreatmentoflivercancerinthecovid19era AT wangxiaohu theroletransitionofradiotherapyforthetreatmentoflivercancerinthecovid19era AT lizheng roletransitionofradiotherapyforthetreatmentoflivercancerinthecovid19era AT huyue roletransitionofradiotherapyforthetreatmentoflivercancerinthecovid19era AT zengming roletransitionofradiotherapyforthetreatmentoflivercancerinthecovid19era AT huqinyong roletransitionofradiotherapyforthetreatmentoflivercancerinthecovid19era AT yefei roletransitionofradiotherapyforthetreatmentoflivercancerinthecovid19era AT liuruifeng roletransitionofradiotherapyforthetreatmentoflivercancerinthecovid19era AT caihongyi roletransitionofradiotherapyforthetreatmentoflivercancerinthecovid19era AT liqiang roletransitionofradiotherapyforthetreatmentoflivercancerinthecovid19era AT wangxiaohu roletransitionofradiotherapyforthetreatmentoflivercancerinthecovid19era |